Bayer AG (BAYN.DE) shares climbed significantly in midday trading, pushing the company to the top of the DAX index.
The rally was fueled by a combination of positive analyst commentary from Deutsche Bank and market approval of the company's strategy to spin off its controversial glyphosate business.
81 points, driven by strong international market performance.
Investors appear to be rewarding the structural clarity offered by the separation of the herbicide unit, which has long been a source of legal and reputational risk for the conglomerate.
The stock's performance stands out against a broader backdrop of recovery for German equities.
The DAX closed sharply higher on Tuesday, surging 1.5% to settle at 24,995.81 points, driven by strong international market performance.
Bayer's intraday strength suggests that company-specific catalysts are currently outweighing general market sentiment, with traders positioning for a potential turnaround in the stock's long-term trajectory.